Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections.
Blaise
D
D
Stoppa
A M
AM
Viens
P
P
Sainty
D
D
Fossat
C
C
Miquel
M
M
Olive
D
D
Bouabdallah
R
R
Gabert
J
J
Baume
D
D
D001424:Bacterial Infections / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D009369:Neoplasms / Q000628:therapy
D007376:Interleukin-2